Comparison of RNA-Seq and Microarray in Transcriptome Profiling of Activated T Cells
Сравнение RNA-Seq и микрочипов при профилировании транскриптома активированных T-клеток
2014-01-16
SCID: 54.1/b6gjgmd3
Discuss with AI
RNA-SeqT cell activationdifferentially expressed genesmicroarraytranscriptome profiling
Figures from the paper
Abstract (AI)
To demonstrate the benefits of RNA-Seq over microarray in transcriptome profiling, both RNA-Seq and microarray analyses were performed on RNA samples from a human T cell activation experiment. In contrast to other reports, our analyses focused on the difference, rather than similarity, between RNA-Seq and microarray technologies in transcriptome profiling. A comparison of data sets derived from RNA-Seq and Affymetrix platforms using the same set of samples showed a high correlation between gene expression profiles generated by the two platforms. However, it also demonstrated that RNA-Seq was superior in detecting low abundance transcripts, differentiating biologically critical isoforms, and allowing the identification of genetic variants. RNA-Seq also demonstrated a broader dynamic range than microarray, which allowed for the detection of more differentially expressed genes with higher fold-change. Analysis of the two datasets also showed the benefit derived from avoidance of technical issues inherent to microarray probe performance such as cross-hybridization, non-specific hybridization and limited detection range of individual probes. Because RNA-Seq does not rely on a pre-designed complement sequence detection probe, it is devoid of issues associated with probe redundancy and annotation, which simplified interpretation of the data. Despite the superior benefits of RNA-Seq, microarrays are still the more common choice of researchers when conducting transcriptional profiling experiments. This is likely because RNA-Seq sequencing technology is new to most researchers, more expensive than microarray, data storage is more challenging and analysis is more complex. We expect that once these barriers are overcome, the RNA-Seq platform will become the predominant tool for transcriptome analysis.
Key Findings
1
Microarrays remain more widely used because RNA-Seq is more expensive and presents greater data-storage and computational-analysis challenges.
2
RNA-Seq and Affymetrix microarray gene-expression profiles showed high correlation when analyzing identical activated human T-cell samples.
3
RNA-Seq avoided microarray probe-related problems, including cross-hybridization, nonspecific hybridization, limited probe detection ranges, redundancy, and annotation dependence.
4
RNA-Seq more effectively detected low-abundance transcripts, distinguished biologically important isoforms, and identified genetic variants than microarrays.
5
RNA-Seq provided a broader dynamic range, enabling detection of more differentially expressed genes and larger fold-changes.
Research Object
Transcriptomes of human T cells activated in an experimental activation model
Research Subject
Differences in transcriptome profiling performance between RNA-Seq and microarray, including detection of low-abundance transcripts, isoform discrimination, genetic-variant identification, dynamic range, and differential-expression detection
Publication Details
Publication Date
2014-01-16
Journal
Publisher
ISSN
Cited by
943
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest